ACTIVATED AND EXPANDED NATURAL KILLER (NKAE) CELLS KILL MULTIPLE MYELOMA (MM) CLONOGENIC PLASMA CELLS THROUGH NKG2D AND NKP30 RECEPTORS AND THEIR LIGANDS

被引：0
|
作者：
Leivas, A. [1 ]
Risueno, R. M. [2 ]
Perez-Martinez, A. [3 ]
Fernandez-Casanova, L. [4 ]
Lahuerta, J. J. [1 ]
Martinez-Lopez, J. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Hematol Serv, Madrid, Spain
[2] Josep Carreras Leukemia Res Inst, Leukemia Stem Cell Grp, Barcelona, Spain
[3] Hosp Univ La Paz, Pediat Oncohematol Serv, Madrid, Spain
[4] Ctr Nacl Invest Oncol, Madrid, Spain
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P332
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [31] The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells
    Baeriswyl, Vanessa
    Wodnar-Filipowicz, Aleksandra
    Kalberer, Christian P.
    HAEMATOLOGICA, 2006, 91 (11) : 1538 - 1541
  • [32] Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
    Whalen, Kerry A.
    Rakhra, Kavya
    Mehta, Naveen K.
    Steinle, Alexander
    Michaelson, Jennifer S.
    Baeuerle, Patrick A.
    MABS, 2023, 15 (01)
  • [33] Cytotoxicity of Natural Killer Cells Activated Through NKG2D Contributes to the Development of Bronchiolitis Obliterans in a Murine Heterotopic Tracheal Transplant Model
    Kawakami, T.
    Ito, K.
    Matsuda, Y.
    Noda, M.
    Sakurada, A.
    Hoshikawa, Y.
    Okada, Y.
    Ogasawara, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2338 - 2349
  • [34] The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells
    Lee, Young Shin
    Heo, Woong
    Nam, Jiho
    Jeung, Young Hwa
    Bae, Jaeho
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (03) : 245 - 252
  • [35] Interleukin 15 Primes Natural Killer Cells to Kill via NKG2D and cPLA2 and This Pathway Is Active in Psoriatic Arthritis
    Tang, Fangming
    Sally, Benjamin
    Ciszewski, Cezary
    Abadie, Valerie
    Curran, Shane A.
    Groh, Veronika
    FitzGerald, Oliver
    Winchester, Robert J.
    Jabri, Bana
    PLOS ONE, 2013, 8 (09):
  • [36] Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: Evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2D
    Poggi, Alessandro
    Zocchi, Maria Raffaella
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2006, 13 (2-4): : 325 - 336
  • [37] Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands
    Domaica, Carolina I.
    Fuertes, Mercedes B.
    Rossi, Lucas E.
    Girart, Maria V.
    Avila, Damian E.
    Rabinovich, Gabriel A.
    Zwirner, Norberto W.
    EMBO REPORTS, 2009, 10 (08) : 908 - 915
  • [38] Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells
    Ogbomo, Henry
    Michaelis, Martin
    Klassert, Denise
    Doerr, Hans W.
    Cinatl, Jindrich
    NEOPLASIA, 2008, 10 (12): : 1402 - 1410
  • [39] Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
    Baumeister, Susanne H.
    Murad, Joana
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Gicobi, Joanina K.
    Schmucker, Adam
    Reder, Jake
    Sentman, Charles L.
    Gilham, David E.
    Lehmann, Frederic F.
    Galinsky, Ilene
    DiPietro, Heidi
    Cummings, Kristen
    Munshi, Nikhil C.
    Stone, Richard M.
    Neuberg, Donna S.
    Soiffer, Robert
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 100 - 112
  • [40] Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
    Petillo, Sara
    Capuano, Cristina
    Molfetta, Rosa
    Fionda, Cinzia
    Mekhloufi, Abdelilah
    Pighi, Chiara
    Antonangeli, Fabrizio
    Zingoni, Alessandra
    Soriani, Alessandra
    Petrucci, Maria Teresa
    Galandrini, Ricciarda
    Paolini, Rossella
    Santoni, Angela
    Cippitelli, Marco
    CELL DEATH & DISEASE, 2021, 12 (09)
12345